The role of pro-inflammatory molecules and pharmacological agents in acute pancreatitis and sepsis

Inflammation and Allergy - Drug Targets

Volumn 9, Issue 1, 2010, Pages 20-31

  Shanmugam, Muthu Kumaraswamy ^a   Bhatia, Madhav ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Acute pancreatitis; Animal models; Chemokines; Cytokines; Hydrogen sulfide; Inflammation; Pancreas; Pharmacological agents; Sepsis

Indexed keywords

1 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYL 1 PIPERAZINYL] 2 OXOETHOXY]PHENYL]UREA; 3 AMINOBENZAMIDE; ACETYLCYSTEINE; ANTIBIOTIC AGENT; CELL ADHESION MOLECULE; CERULETIDE; CHEMOKINE; CXCL1 CHEMOKINE; CYTOKINE; E 5531; GABEXATE MESILATE; HYDROGEN SULFIDE; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 2; MELATONIN; NACYSTELYN; NITROGEN OXIDE; OCTREOTIDE; PENTOXIFYLLINE; PROBIOTIC AGENT; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SOMATOSTATIN; STEROID; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ACINAR CELL; ACUTE PANCREATITIS; APOPTOSIS; CELL DEATH; CELL INFILTRATION; CLINICAL TRIAL; DISEASE COURSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; INFLAMMATION; INFLAMMATORY INFILTRATE; MULTIPLE ORGAN FAILURE; OBESITY; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; STANDARDIZED INCIDENCE RATIO; STELLATE CELL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 77949388161     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152810791292881     Document Type: Review

References (175)

1. Imrie, C.W. Acute pancreatitis: Overview Eur. J. Gastroenterol. Hepatol., 1997, 9, 103-05.
2. McKay, C.J.; Buter, A. Natural history of organ failure in acute pancreatitis. Pancreatology, 2003, 3(2), 111-14.
3. Weber, C.K.; Adler, G. Acute pancreatitis. Curr. Opin. Gastroenterol., 2003, 19(5), 447-50.
4. Granger, J.; Remick, D. Acute pancreatitis: models, markers, and mediators. Shock, 2005, 24(1), 45-51.
5. Buter, A.; Imrie, C.W.; Carter, C.R.; Evans, S.; McKay, C.J. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br. J. Surg., 2002, 89(3), 298-302.
6. Bhatia, M.; Brady, M.; Shokuhi, S.; Christmas, S.; Neoptolemos, J.P.; Slavin, J. Inflammatory mediators in acute pancreatitis. J. Pathol. 2000, 190, 117-25.
7. Bhatia, M.; Neoptolemos, J.P.; Slavin, J. Inflamatory mediators as therapeutic targets in acute pancreatitis. Curr. Opin. Investig. Drugs., 2001, 2, 496-501.
8. Bhatia, M. Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr. Drug. Targets. Inflamm. Allergy, 2002, 1, 343-51.
9. Whitcomb, D.C. Genetic polymorphisms in alcoholic pancreatitis. Dig. Dis. Sci., 2005, 23, 247-54.
10. Ohmuraya, M.; Yamamura, K.I. Autophagy and acute pancreatitis: A novel autophagy theory for trypsinogen activation. Autophagy, 2008, 4(8), 1060-2.
11. Whitcomb, D.C.; Gorry, M.C.; Preston, R.A.; Furey, W.; Sossenheimer, M.J.; Ulrich, C.D.; Martin, S.P.; Gates, L.K.Jr.; Amann, S.T.; Toskes, P.P.; Liddle, R.; McGrath, K.; Uomo, G.; Post, J.C.; Ehrlich, G.D. Hereditary pancreatitis is caused by mutation in the cationic trypsinogen gene. Nat. Genet., 1996, 14, 141-45.
12. Frossard, J.L.; Steer, M.L.; Pastor, C.M. Acute pancreatitis. Lancet, 2008, 371, 143-152.
13. Vonlaufen, A.; Wilson, J.S.; Apte, M.V. Molecular mechanisms of pancreatitis: current opinion. J. Gastroenterol. Hepatol., 2008, 23(9), 1339-48.
14. Lampel, M.; Kern, H. Virchows. Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Arch. A. Pathol. Anat. Histol., 1977, 2, 97-117.
15. Bhatia, M.; Brady, M.; Zagorski, J.; Christmas, S.E.; Campbell, F.; Neoptolemos, J.P.; Salvin, J. Treatment with neutralizing antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut, 2000, 47, 838-44.
16. Murphy, P.M. The molecular biology of leukocyte chemoattractant receptor. Annu. Rev. Immunol., 1994, 12, 593-633.
17. Ramudo, L.; Manso, M.A.; Sevillano, S.; de Dios, I. Kinetic study of TNFα production and its regulatory mechanisms in acinar cells during acute pancreatitis induced by bile-pancreatic duct obstruction. J. Pathol., 2005a, 206, 9-16.
18. Grady, T.; Liang, P.; Ernst, S.A.; Logsdon, D.C. Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology, 1997, 6, 1966-1975.
19. Ramnath, R.D.; Ng, S.W.; Guglielmotti, A.; Bhatia, M. Role of MCP-1 in endotoxemia and sepsis. Int. Immunopharmacol., 2008, 8, 810-8.
20. Gukovskaya, A.S.; Gukovsky, I.; Zaninovic, V.; Song, M.; Sandoval, D.; Gukovsky, S.; Pandol, S.J. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J. Clin. Invest., 1997, 7, 1853-62.
21. Brady, M.; Bhatia, M.; Christmas, S.; Boyd, M.T.; Neoptolemos, J.P.; Salvin, J. Expression of the chemokines MCP-1/JE and cytokine-induced neutrophil chemoattractant in early acute pancreatitis. Pancreas, 2002, 25(3), 260-9.
22. Bhatia, M.; Brady, M.; Kg Kang, Y.; Costello, E.; Newton, D.J.; Christmas, S.E.; Neoptolemos, J.P.; Salvin, J. MCP-1 but not CINC synthesis is increased in rat pancreatic acini in response to cerulein hyperstimulation. Am. J. Physiol. Gastrointest. Liv. Physiol., 2002, 282(145-1), G77-85.
23. Bone-Larson, C.L.; Hogaboam, C.M.; Steinhauser, M.L.; Oliveira, S.H.P.; Lukacs, N.W.; Strieter, R.M.; Kunkel, S.L. Novel protective effects of stem cell factor in a murine model of acute septic peritonitis: Dependence on MCP-1. Am. J. Pathol., 2000, 157(4), 1177-86.
24. Apte, M.; Phillips, P.; Wu, M-J.; Friess, H.; Buchler, M.; Korsten, M.; Wilson, J. Endogenous expression of proinflammatory cytokines and nerve growth factor by pancreatic stellate cells - implications for fibrosis and neural changes in chronic pancreatitis. Pancreas, 2001, 23, 428-
25. Shimizu, K.; Kobayashi, M.; Tahara, J.; Shiratori, K. Cytokines and peroxisome proliferator activated receptor gamma ligand regulate phagocytosis by pancreatic stellate cells. Gastoenterology, 2005, 7, 2105-18.
26. Pastor, C.M.; Vonlaufen, A.; Gerogi, F.; Hadengue, A.; Morel.; Fossard, J.L. Neutrophil depletion - but not prevention of Kupffer cell activation - decreases the severity of cerulein -induced acute pancreatitis. World. J. Gastroenterol., 2006, 8, 1219-24.
27. Pastor, C.M.; Rubbia-Brandt, L.; Hadengue, A.; Jordan, M.; Morel, P.; Frossard, J.L. Role of macrophage inflammatory peptide-2 in cerulein-induced acute pancreatitis- associated lung injury. Lab. Invest., 2003, 4, 471-8.
28. Demols, A.; Le Moine, O.; Desalle, F.; Quertinmont, E.; Van Laethem, J.L.; Deviere, J. CD4+ T cells play an important role in acute experimental pancreatitis in mice. J. Gastroenterol., 2000, 3, 582-90.
29. Frossard, J.L.; Kwak, B.; Chanson, M.; Morel, P.; Hadengue, A.; Mach, F. Cd40 ligand-deficient mice are protected against cerulein induced acute pancreatitis and pancreatitis associated lung injury. Gastroenterology, 2001, 1, 184-94.
30. Zhang, H.; Bhatia, M. Hydrogen sulfide: a novel mediator of leukocyte activation. Immunopharcol. Immunotoxicol., 2008, 30(4), 631-45.
31. Imhof, B.A.; Dunon, D. Leukocyte migration and adhesion. Adv. Immunol., 1995, 58, 345-416.
32. Williamson, J.R.; Grisham, J.W. Electron microscopy of leukocytic margination and emigration in acute inflammation in dog pancreas. Am. J. Pathol. 1961, 39, 239-56.
33. Telek, G.; Ducroc, R.; Socazec, J.Y.; Pasquier, C.; Feldmann, G.; Roze, C. Differential up-regulation of cellular adhesion molecules at the sites of oxidative stress in experimental acute pancreatitis. J. Surg. Res., 2001, 1, 56-67.
34. Folch, E.; Salas, A.; Panes, J.; Gelpi, E.; Rosello-Catafau, J.; Anderson, D.C.; Navarro, S.; Piqué, J.M.; Fernández-Cruz, L.; Closa, D. Role of P-selectin and ICAM-1 in pancreatitis induce lung inflammation in rats: significance of oxidative stress Ann. Surg., 1999, 6, 792-8.
35. Bernot, D.; Peiretti, F.; Canault, M.; Juhan-Vague, I.; Nalbone, G. Up-regulation of TNF?? induced ICAM-1 surface expression by adenylate cyclase dependent pathway in human endothelial cells. J. Cell Physiol., 2005, 2, 434-41.
36. Harwig, W.; Werner, J.; Warshaw, A.L.; Antoniu, B.; Castillo, C.F.; Gebhard, M.M.; Uhl, W.; Buchler, M.W. Membrane bound ICAM-1 is upregulated by trypsin and contributes to leukocyte migration in acute pancreatitis. Am. J. Physiol. Gastrointest. Liver. Physiol., 2004, 287, G1194-9.
37. Frossard, J.L.; Saluja, A.; Bhagat, L.; Lee, H.S.; Bhatia, M.; Hofbauer, B.; Steer, M.L. The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis associated lung injury. Gastroenterology, 1999, 116, 694-701.
38. Lundberg, A.H.; Granger, N.; Russell, J.; Callicutt, S.; Gaber, L.W.; Kotb, M.; Sabek, O.; Gaber, A.O. Temporal correlation of tumor necrosis factor alpha release, up regulation of pulmonary ICAM-1 and VCAM-1, neutrophil sequestration, and lung injury in diet-induced pancreatitis. J. Gastrointest. Surg., 2000, 3, 248-57.
39. Hu, J.; Van den Steen, P.E.; Sang, Q.A.; Opdenakkar, G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug. Dis., 2007, 6, 480-98.
40. Müller-Pillasch, F.; Gress, T.M.; Yamaguchi, H.; Geng, M.; Adler, G.; Menke, A. The influence of transforming growth factor β1 on the expression of genes coding for matrix metalloproteinases and tissue inhibitors of metalloproteinases during regeneration from cerulein induced pancreatitis. Pancreas, 1997, 15, 168-75.
41. Descamps, F.J.; Martens, E.; Ballaux, F.; Geboes, K.; Opdenakker, G. In vivo activation fo gelatinase B/MMP-9 by trypsin in acute pancreatitis is a permissive factor in streptozotocin induced diabetes. J. Pathol., 2004, 204, 555-61.
42. Vonlaufen, A.; Apte, M.V.; Imhof, B.A.; Frossard, J.L. The role of inflammatory and parencymal cells in acute panreatitis. J. Pathol., 2007, 213(3), 239-48.
43. Bhatia, M.; Saluja, A.K.; Singh, V.P.; Frossard, J.L.; Lee, H.S.; Bhagat, L.; Gerard, C.; Steer, M.L. Complement factor C5a exerts an anti-inflammatory effect in acute pancreatitis and associated lung injury. Am. J. Physiol. Gastrointest. Liver Physiol., 2001, 280(543-5), G974-8.
44. Rittirsch, D.; Flierl, M.A.; Nadeau, B.A.; Day, D.E.; Huber-Lang, M.; Mackay, C.R.; Zetoune, F.S.; Gerard, N.P.; Cianflone, K.; Köhl, J.; Gerard, C.; Sarma, J.V.; Ward, P.A. Functional roles for C5a receptors in sepsis. Nat. Med., 2008, 14(5), 551-7.
45. Zyromski, N.J.; Mathur, A.; Pitt, H.A.; Lu, D.; Gripe, J.T.; Walker, J.J.; Yancey, K.; Wade, T.E.; Swartz-Basile, D.A. A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol., 2008, 295(3), G552-8.
46. Czakó, L.; Szabolcs, A.; Vajda, A.; Csáti, S.; Venglovecz, V.; Rakonczay Jr, Z.; Hegyi, P.; Tiszlavicz, L.; Csont, T.; Pósa, A.; Berkó, A.; Varga, C.; Varga Ilona, S.; Boros, I.; Lonovics, J. Hyperlipidemia induced by a cholesterol-rich diet aggravates necrotizing pancreatitis in rats. Eur. J. Pharmacol., 2007, 572(1), 74-81.
47. Rovira, M.; Delaspre, F.; Massumi, M.; Serra, S.A.; Valverde, M.A.; Lloreta, J.; Dufresne, M.; Payré, B.; Konieczny, S.F.; Savatier, P.; Real, F.X.; Skoudy, A. Murine embryonic stem cell-derived pancreatic acinar cells recapitulate features of early pancreatic differentiation. Gastroenterology, 2008, 135, 1301.
48. Lankirsh, P.G.; Lerch, M.M. Pharmacological prevention and treatment of acute pancreatitis: where are we now. Dig. Dis., 2006, 24(1-2), 148-59.
49. Bhatia, M.; Wong, F.L.; Cao, Y.; Lau, H.Y.; Huang, J.; Puneet, P.; Chevali, L. Pathophysiology of acute pancreatitis. Pancreatology, 2005, 5(2-3), 132-44.
50. Foitzik, T.; Hotz, H.G.; Eibl, G.; Buhr, H.J. Experimental models of acute pancreatitis: are they suitable for evaluating therapy? Int. J. Colorectal. Dis., 2000, 15, 127-35.
51. Schmid, S.W.; Uhl, W.; Kidd, M.; Modlin, I.M.; Buchler, M.W. In Markus, W.B.; Uhl, W.; Malfertheiner, P., Eds. Acute pancreatits: novel concepts in biology and therapy. Malden MA: Blackwell Science 1998; pp. 52-62.
52. Niederau, C.; Ferrell, L.D.; Grendell, J.H. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin. Gastroenterology, 1985, 88, 1192-204.
53. Lombardi, B.; Estes, L.W.; Longnecker, D.S. Acute hemorrhagic pancreatitis (massive necrosis) with fat necrosis induced in mice by DL-ethionine fed with a choline-deficient diet. Am. J. Pathol., 1975, 79, 465-80.
54. Lerch, M.M.; Saluja, A.K.; Dawra, R.; Ramarao, P.; Saluja, M.; Steer, M.L. Acute necrotizing pancreatitis in the opossum: earliest morphological changes involve acinar cells. Gastroenterology, 1992, 103, 205-13.
55. Saluja, A.; Saluja, M.; Villa, A.; Leli, U.; Rutledge, P.; Meldolesi, J.; Steer, M. J. Pancreatic duct obstruction in rabbits causes digestive zymogen and lysosomal enzyme colocalization. Clin. Invest., 1989, 84(4), 1260-6.
56. Aho, H.J.; Koskensalo, S.M.; Nevalainen, T. Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. J. Scand. J. Gastroenterol., 1980, 15, 411-6.
57. Hartwig, W.; Schimmel, E.; Hackert, T.; Fortunato, F.; Bergmann, F.; Baczako, A.; Strobel, O.; Buchler, M.W.; Werner, J. A novel animal model of severe pancreatitis in mice and its difference to the rat. Surgery, 2008, 144, 394-403.
58. Dawra, R.; Sharif, R.; Phillips, P.; Dudeja, V.; Dhaulakhandi, D.; Saluja, A.K. Development of a new mouse model of acute pancreatitis induced by administration of L-arginine. Am. J. Physiol. Gastrointest. Liver. Physiol., 2007, 292, G1009-18.
59. Laukkarinen, J.M.; Van Acker, G.J.; Weiss, E.; Steer, M.L.; Perides, G. A mouse model of acute biliary pancreatitis induced by retrogradepancreatic duct infusion of Na-taurocholate. Gut, 2007, 56, 1590-8.
60. Mareninova, O.A.; Sung, K.F.; Hong, P.; Lugea, A.; Pandol, S.J.; Gukovsky, I.; Gukovskaya, A.S. Cell death in pancreatitis: caspases protect from necrotizing pancreatitis. J. Biol. Chem., 2006, 281, 3370-81.
61. Bhatia, M. Apoptosis versus necrosis in acute pancreatitis. Am. J. Physiol. Gastrointest. Liver. Physiol., 2004, 286, G189-96.
62. Wilson, P.G.; Manji, M.; Neopltolemos, J.P. Acute pancreatitis as a model of sepsis. J. Antimicrob. Chemother., 1998, 41, 51-63.
63. Angus, D.C.; Linde-Zwirble, W.T.; Lidicker, J.; Clermont, G.; Carcillo, J.; Pinsky, M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care. Med., 2001, 29, 1303-10.
64. Remick, D.G. Pathophysiology of sepsis. Am. J. Pathol., 2008, 170, 1435-44.
65. Nahra, R.; Dellinger, P.R. Targeting the lipopolysaccharides: still a matter of debate? Curr. Opin. Anaesthesiol., 2008, 21, 98-114.
66. Malleo, G.; Emanuela, M.; Siriwardena, A.K.; Cuzzocrea, S. Role of Tumor necrosis Factor-?? in acute pancreatitis: from biological basis to clinical evidence. Shock, 2007, 28, 130-40.
67. Malleo, G.; Mazzon, E.; Genovese, T.; Di Paola, R.; Muia, C.; Centorrino, T.; Siriwardena, A.K.; Cuzzocrea, S. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice. A comparison with TNF-?? genetic deletion. Shock, 2007, 27, 542-51.
68. Mazzone, E.; Genovese, T.; Di Paola, R.; Muia, C.; Crisafull, C.; Malleo, G.; Esposito, E.; Meli, R.; Sessa, E.; Cuzzocrea, S. Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein. Eur. J. Pharmacol., 2006, 549, 149-56.
69. Frossard, J.L.; Morel, P.; Pastor, C.M. Why clinical trials might succeed in acute pancreatitis when they failed in septic shock. J. Pancreas, 2003, 4, 11-16.
70. Williams, L.M.; Lali, F.; Willetts, K.; Balaque, C.; Godessart, N.; Brennan, F.; Feldmann, M.; Foxwell, B.M. Rac mediates TNF-induced cytokine production via modulation of NFkappaB. Mol. Immunol., 2008, 45(9), 2446-54.
71. Sullivan, K.E.; Reddy, A.B.M.; Dietzmann, K.; Suriano, A.R.; Kocieda, V.P.; Stewart, M.; Bhatia, M. Epigenetic regulation of tumor necrosis factor alpha. Mol. Cell. Biol., 2007, 27(14), 5147-60.
72. Zhang, H.; Zhi, L.; Moochhala, S.M.; Moore, P.K.; Bhatia, M. Endogenous hydrogen sulfide regulates leukocyte trafficking in cecal ligation and puncture-induced sepsis. J. Leukoc. Biol., 2007, 82, 894-905.
73. Li, L.; Bhatia, M.; Zhu, Y.Z.; Ramnath, R.D.; Wang, Z.J.; Anuar, F.; Whiteman, M.; Salto-Tellez, M.; Moore, P.K. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse FASEB. J., 2005, 19, 1196-98.
74. Li, L.; Moore, P.K. An overview of the biological significance of endogenous gases: new roles for old molecules. Biochem. Soc. Trans., 2007, 35(5), 1138-41.
75. Zhang, H.; Moochhala, S.M.; Bhatia, M. Endogenous hydrogen sulfide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis. J. Immunol., 2008, 181, 4320-31.
76. Severini, C.; Improta, G.; Falconieri-Erspamer, G.; Salvadori, S.; Erspamer, V. The tachykinin peptide family. Pharmacol. Rev., 2002, 54, 285-322.
77. Hegde, A.; Bhatia, M. Neurogenic inflammation in acute pancreatitis. JOP, 2005, 6, 417-21.
78. Bhatia, M.; Slavin, J.; Cao, Y.; Basbaum, A.I.; Neoptolemos, J.P. Proprotachykinin-A gene deletion protects mice against acute pancreatitis and associated lung injury. Am. J. Physiol. Gastrointes. Liver. Physiol., 2003, 284, G830-36.
79. Puneet, P.; Hegde, A.; Ng, S.W.; Lau, H.Y.; Lu, J.; Moochhala, S.; Bhatia, M. Preprotachykinin-A gene products are key mediators of lung injury in polymicrobial sepsis. J. Immunol., 2006, 176, 3813-20.
80. Hegde, A.; Zhang, H.; Moochhala, S.M.; Bhatia, M. Neurokinin 1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis. J. Leukoc. Biol., 2007, 82, 678-85.
81. Ng, S.W.; Zhang, H.; Hegde, A.; Bhatia, M. Role of preprotachykinin-A gene products on multiple organ injury in LPS-induced endotoxemia. J. Leukoc. Biol., 2008, 83, 288-95.
82. Vachharajani, V. Influence of obesity on sepsis. Pathophysiology, 2008, 15(2), 123-34.
83. Oberholzer, C.; Oberholzer, A.; Clare-Salzler, M.; Moldawer, L.L. Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J., 2001, 15, 879-92.
84. Wesche, D.E.; Lomas-Neira, J.L.; Perl, M.; Chung, C.S.; Ayala, A. Leukocyte apoptosis and its significance in sepsis and shock. J. Leukoc. Biol., 2005, 78, 325-37.
85. Hotchkiss, R.S.; Chang, K.C.; Grayson, M.H.; Tinsley, K.W.; Dunne, B.S.; Davis, C.G.; Osborne, D.F.; Darl, I.E. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc. Natl. Acad. Sci. USA, 2003, 100, 6724-29.
86. Brown, K.; Brain, S.D.; Pearson, J.D.; Edgeworth, J.D.; Lewis, S.M.; Treacher, D.F. Neutrophils in development of multiple organ failure in sepsis. Lancet, 2006, 368, 157-69.
87. Chishti, A.D.; Shenton, B.K.; Kirby, J.A.; Baudouin, S.V. Neutrophil chemotaxis and receptor expression in clinical septic shock. Intensive Care Med., 2004, 30, 605-11.
88. He, M.; Horuk, R.; Bhatia, M. Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modulating neutrophil recruitment. Pancreas, 2007a, 34(2), 233-41.
89. Kaneider, N.C.; Agarwal, A.; Leger, A.J.; Kuliopulos, A. Reversing systemic inflammatory response syndrome with chemokine receptor pepducins. Nat. Med., 2005, 11, 661-5.
90. Taneja, R.; Parodo, J.; Jia, S.H.; Kapus, A.; Rotstein, O.D.; Marshall, J.C. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit. Care Med., 2004, 32, 1460-9.
91. Biswal, S.; Remick, D.G. Sepsis:Redox mechanisms and Therapeutic Opportunities. Antioxid. Redox. Signal, 2007, 9(11), 1959-61.
92. Asehnoune, K.; Strassheim, D.; Mitra, S.; Kim, J.Y.; Abraham, E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NFκB. J. Immunol. 2004, 172, 2522-9.
93. Mitra, S.; Abraham, E. Participation of superoxide in neutrophil activation and cytokine production. Biochim. Biophys. Acta, 2006, 1762, 732-41.
94. Nakahira, K.; Kim, H.P.; Geng, X.H.; Nakao, A.; Wang, X.; Murase, N.; Drain, P.F.; Sasidhar, M.; Nabel, E.G.; Takahashi, T.; Lukacs, N.W.; Ryter, S.W.; Morita, K.; Choi, A.M. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J. Exp. Med., 2006, 203, 2377-89.
95. Xing, L.; Remick, D. Promoter elements responsible for antioxidant regulation of MCP1 gene expression. Antioxid. Redox Signal, 2007, 9, 1979-89.
96. Wesche, D.E.; Lomas-Neira, J.L.; Perl, M.; Chung, C.S.; Ayala, A. Leukocyte apoptosis and its significance in sepsis and shock. J. Leukoc. Biol., 2005, 78(2), 325-37.
97. Russell, J.A. Management of sepsis. N. Engl. J. Med., 2006, 355, 1699-713.
98. Turrel, F.; Guignant, C.; Venet, F.; Lepape, A.; Monneret, G. Innovative therapeutic strategies for restoring lymphocyte functions in septic patients. Inflamm. Allergy Drug Targets, 2008, 7, 181-6.
99. Szabo, C. Hydrogen sulfide and its therapeutic potential. Nat. Rev. Drug Discov., 2007, 6(11), 917-35.
100. Hoetzel, A.; Dolinay, T.; Schmidt, R.; Choi, A.M.K.; Ryter, S.W. Carbon monoxide in sepsis. Antioxid. Redox Signal, 2007, 9, 2013-26.
101. Moore, P.K.; Bhatia, M.; Moochhala, S. Hydrogen sulfide: from the smell of the past to the mediator of the future? Trends Pharmacol. Sci., 2003, 24(12), 609-11.
102. Bhatia, M. Hydrogen sulfide as a vasodilator. IUBMB life, 2005, 57(9), 603-06.
103. Miles, E.W.; Kraus, J.P. Cystathionine β synthase: Structure, function, regulation, and location of homocystinuria-causing mutation. J. Biol. Chem., 2004, 279(29), 29871-4.
104. 2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine γ-lyase. Science, 2008, 322(5901), 587-90.
105. Sun, Q.; Collins, R.; Huang, S.; Holmberg-Schiavone, L.; Anand, G.S.; Tan, C.H.; Van-den-Berg, S.; Deng, L.W.; Moore, P.K.; Karlberg, T.; Sivaraman, J. Structural Basis for the inhibition mechanism of human cystathionine-gamma -Lyase: An enzyme responsible for the production of H2S. J. Biol. Chem., 2008, 284(5), 3076-85.
106. 2S be the third endogenous gaseous transmitter? FASEB J., 2002, 16, 1792.
107. Zhang, H.; Zhi, L.; Moore, P.K.; Bhatia, M. Role of hydrogen sulfide in cecal ligation and puncture induced sepsis in the mouse. Am. J. Physiol. Lung Cell Mol. Physiol., 2006, 290, L1193-201.
108. Zhang, H.; Moochhala, S.M.; Bhatia, M. Endogenous hydrogen sulphide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis. J. Immunol., 2008, 181, 4320-31.
109. Collin, M.; Anuar, F.B.M.; Murch, O.; Bhatia, M.; Moore, P.K.; Thiemermann, C. Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br. J. Pharmacol., 2005, 146, 498-05.
110. Bhatia, M.; Wong, F.L.; Fu, D.; Lau, H.Y.; Moochhala, S.; Moore, P.K. Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J., 2005, 19, 623-5.
111. Tamizhselvi, R.; Moore, P.K.; Bhatia, M. Hydrogen sulfide acts as a mediator of inflammation in acute pancreatitis: in vitro studies using isolated mouse pancreatic acinar cells. J. Cell Mol. Med., 2007, 11(2), 315-26.
112. Ramasamy, T.; Moore, P.K.; Bhatia, M. Inhibition of hydrogen sulfide synthesis attenuates chemokine production and protects mice against acute pancreatitis and associated lung injury. Pancreas, 2008, 36(4), e24-31.
113. 2S-induced pancreatic acinar cell apoptosis is mediated via JNK and p38 MAP kinase. J. Cell Mol. Med., 2008, 12(4), 1374-83.
114. Bhatia, M.; Saluja, A.K.; Hofbauer, B.; Fossard, J.L.; Lee, H.S.; Castagliuolo, I.; Wang, C.C.; Gerard, N.; Pothoulakis, C.; Steer, M.L. Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis associated lung injury. Proc. Natl. Acad. Sci. USA., 1998, 95, 4760-5.
115. Lau, H.Y.; Wong, F.L.; Bhatia, M. A key role of neurokinin 1 receptor in acute pancreatitis associated lung injury. Biochem. Biophys. Res. Commun., 2005, 327, 509-15.
116. Zhang, H.; Hegde, A.; Ng, S.W.; Adhikari, S.; Moochhala, S.M.; Bhatia, M. Hydrogen sulfide up-regulates substance P in polymicrobial sepsis-associated lung injury. J. Immunol., 2007, 179(6), 4153-60.
117. Bhatia, M.; Zhi, L.; Zhang, H.; Ng, S.W.; Moore, P.K. Role of substance P in hydrogen sulfide induced pulmonary inflammation in mice. Cell Physiol., 2006, 291, L896-904.
118. Bhatia, M.; Sidhapuriwala, J.; Ng, S.W.; Tamizhselvi, R.; Moochhala, S. Proinflammatory effects of hydrogen sulfide on substance P in caerulin-induced acute pancreatitis. J. Cell. Mol. Med., 2008, 12(2), 580-90.
119. Bang, U.C.; Semb, S.; Nojgaard, C.; Bendtsen, F. Pharmacological approach to acute pancreatitis. World J. Gastroenterol., 2008, 14(19), 2968-76.
120. Cheng, B.Q.; Liu, C.T.; Li, W.J.; Fan, W.; Zhong, N.; Zhang, Y.; Jia, X.Q.; Zhang, S.Z. Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis. Pancreas, 2007, 35, 256-61.
121. Fink, M.P. Ethyl pyruvate. Curr. Opinion Anesthesiol., 2008, 21, 160-7.
122. Vosters, O.; Beuneu, C.; Goldman, M.; Verhasselt, V. Nacetylcyteine derivative inhibits CD40-dependent proinflammatory properties of human pancreatic duct cells. Pancreas, 2008, 36(4), 363-8.
123. Ramudo, L.; Manso, M.A.; Vincente, S.; De dios, I. Pro- and anti-inflammatory response of acinar cells during acute pancreatitis. Effect of N-acetyl cysteine. Cytokine, 2005, 32, 125-31.
124. Jaworek, J.; Nawrot-porabka, K.; Leja-szpak, A.; Bonior, J.; Szklarczyk, J.; Kot, M.; Konturek, S.J.; Pawlik, W.W. Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. J. Physiol. Pharmacol., 2007, 58(6), 65-80.
125. de Campos, T.; Deree, J.; Martins, J.O.; Loomis, W.H.; Shenvi, E.; Putnam, J.G.; Coimbra, R. Pentoxifylline attenuates pulmonary inflammation and neutrophil activation in experimental acute pancreatitis. Pancreas, 2008, 37(1), 42-9.
126. Christ, W.; Asano, O.; Robidoux, A.L.; Perez, M.; Wang, Y.; Dubuc, G.R.; Gavin, W.E.; Hawkins, L.D.; McGuinness, P.D.; Mullarkey, M.A.; E5531, a pure endotoxin antagonist of high potency. Science, 1995, 268, 80-3.
127. Mullarkey, M.; Rose, J.R.; Bristol, J.; Kawata, T.; Kimura, A.; Kobayashi, S.; Przetak, M.; Chow, J.; Gusovsky, F.; Christ, W.J.; Rossignol, D.P. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4 directed endotoxin antagonist. J. Pharmacol. Exp. Ther., 2003, 304, 1093-102.
128. Wong, Y.N.; Rossignol, D.; Rose, J.R.; Kao, R.; Carter, A.; Lynn, M. Safety, pharmacokinetics and pharmacodynamics of E5564, a lipid A antagonist, during an ascending single-dose clinical study. J. Clin. Pharmacol., 2003, 43, 735-42.
129. Goldfarb, R.D.; Parker, T.S.; Levine, D.M.; Glock, D.; Akhter, I.; Alkhudari, A.; McCarthy, R.J.; David, E.M.; Gordon, B.R.; Saal, S.D.; Rubin, A.L.; Trenholme, G.M.; Parrillo, J.E. Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in procine sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2003, 284, R550-7.
130. Huang, J.; Moochhala, S.M.; Moore, P.K.; Bhatia, M. Flurbiprofen and HCT1026 protect mice against acute pancreatitis-associated lung injury. Shock, 2005, 24(2), 182-7.
131. Venkataraman, R.; Kellum, J.A., Song, M.; Fink, M.P. Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock. Shock, 2002, 18, 507-12.
132. Ulloa, L.; Ochani, M.; Yang, H.; Tanovic, M.; Halperin, D.; Yang, R.; Czura, C.J.; Fink, M.P.; Tracey, K.J. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl. Acad. Sci. USA., 2002, 99, 12351-6.
133. van Zoelen, M.A.; de Vos, A.F.; Larosa, G.J.; Draing, C.; von Aulock, S.; van der Poll, T. Intrapulmonary delivery of ethyl pyruvate attenuates lipopolysaccharide and lipoteichoic acid-induced lung inflammation in vivo. Shock, 2007, 28, 570-5.
134. Satoh, A.; Gukovskaya, A.S.; Nieto, J.M.; Cheng, J.H.; Gukovsky.; Reeve, J.R. Jr.; Shimosegawa, T.; Pandol, S.J. PKC-delta and - epsilon regulate NF-kappaB activation induced by Cholecystokinin and TNF-alpha in pancreatic acinar cells. Am. J. Physiol. Gastrointest. Liver. Physiol., 2004, 287(3), G582-91.
135. Satoh, A.; Gukovskaya, A.S.; Edderkaoui, M.; Daghighian, M.S.; Reeve, J.R. Jr.; Shimosegawa, T.; Pandol, S.J. Tumor necrosis factor-alpha mediates pancreatitis responses in acinar cells via protein kinase C and proline-rich tyrosine kinase 2. Gastroenterology, 2005, 129(2), 639-51.
136. Johnson, G.L.; Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 2002, 298, 1911-2.
137. Criddle, D.N.; McLaughlin, E.; Murphy, J.A.; Petersen, O.H.; Sutton, R. The pancreas misled: signals to pancreatitis. Pancreatology, 2007, 7, 436-446.
138. Criddle, D.N.; Murphy, J.A.; Fistetto, G.; Barrow, S.; Tepikin, A.V.; Neoptolemos, J.P.; Sutton, R.; Petersen, O.H. Fatty acid ethyl esters cause pancreatic calcium toxicity via inositol triphosphate receptors and loss of ATP synthesis. Gastroenterology, 2006, 130, 781-93.
139. Petersen, O.H.; Sutton, R. Ca2+ signaling and pancreatitis: effects of alcohol, bile and coffee. Trends Pharmacol. Sci., 2006, 27, 113-20.
140. Mole, D.J.; McFerran, N.V.; Diamond, T. Differential preservation of lipopolysaccharide-induced chemokine/cytokine expression during experimental pancreatitis-associated organ failure in rats shows a regulatory expressed phenotype. Pancreatology, 2008, 8(4-5), 478-87.
141. Rittirsch, D.; Flierl, M.A.; Ward, P.A. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol., 2008, 8(10), 776-87.
142. Kaneider, N.C.; Leger, A.J.; Agarwal, A.; Nguyen, N.; Perides, G.; Derian, C.; Covic, L.; Kuliopulos, A. 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nat. Immunol., 2007, 8(12), 1303-12.
143. Oruc, N.; Yukselen, V.; Ozutemiz, A.O.; Yuce, G.; Celik, H.A.; Musoglu, A.; Batur, Y. Leukotriene receptor antagonism in experimental acute pancreatitis in rats. Eur. J. Gastroenterol. Hepatol., 2004, 16(4), 383-8.
144. Benjamin, C.F.; Canetti, C.; Cunha, F.Q.; Kunkel, S.L.; Peters-Golden, M. Opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis. J. Immunol., 2005, 174(3), 1616-20.
145. Steendijk, P. Sepsis and intracellular calcium homeostasis, a sparkling story. Crit. Care Med., 2005, 33, 688-90.
146. Williams, A.B.; Decourten-Myers, G.M.; Fischer, J.E.; Luo, G.; Sun, X.; Hasselgren, P.O. Sepsis stimulates release of myofilaments in skeletal muscle by a calcium dependent mechanism. FASEB J, 1999, 13, 1435-43.
147. Merino, V.F.; Todiras, M.; Campos, L.A.; Saul, V.; Popova, E.; Baltatu, O.C.; Pesquero, J.B.; Bader, M. Increased susceptibility to endotoxic shock in transgenic rats with endothelial overexpression of kinin B(1) receptors. J. Mol. Med., 2008, 86(7), 791-8.
148. Chvanov, M.; Gerasimenko, O.V.; Petersen, O.H.; Tepikin, A.V. Calcium-dependent release of NO from intracellular S-nitrosothiol. EMBO J., 2006, 25(13), 3024-32.
149. Fernandez, D.; Assreuy, D. Nitric oxide and vascular reactivity in sepsis. Shock, 2008, 30(1), 10-13.
150. Parrish, W.R.; Gallowitsch-Puerta, M.; Czura, C.J.; Tracey, K.J. Experimental therapeutic strategies for severe sepsis: mediators and mechanisms. Ann. N. Y. Acad. Sci., 2008, 1144, 210-36.
151. Matsuda, N.; Nishihira, J.; Takahashi, Y.; Kemmotsu, O.; Hattori, Y. Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia. Am. J. Respir. Cell Mol. Biol., 2006, 35(2), 198-205.
152. Cunnington, A.; Nadel, S. New therapies for sepsis. Curr. Topics Med. Chem. 2008, 8, 603-14.
153. Love, J.A.; Yi, E.; Smith, T.G. Autonomic pathways regulating pancreatic exocrine secretion. Auton Neurosci., 2007, 133(1), 19-34.
154. Sawa, H.; Ueda, T.; Takeyama, Y.; Yasuda, T.; Shinzeki, M.; Nakajima, T.; Kuroda, Y. Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J. Gastroenterol., 2006, 12(47), 7666-70.
155. Lundberg, A.H.; Granger, D.N.; Russell, J.; Sabek, O.; Henry, J.; Gaber, L.; Kotb, M.; Gaber, A.O. Quantitative measurement of Pand E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury. Ann. Surg., 2000, 231, 213-22.
156. He, M.; Horuk, R.; Moochhala, S.M.; Bhatia, M. Treatment with BX471, a CC chemokine receptor 1 antagonist, attenuates systemic inflammatory response during sepsis. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 292(4), G1173-80.
157. Sabbatini, M.E.; Chen, X.; Ernst, S.A.; Williams, J.A. Rap1 activation plays a regulatory role in pancreatic amylase secretion. J. Biol. Chem., 2008, 283(35), 23884-94.
158. Rakonczay Jr, Z.; Hegyi, P.; Takacs, T.; McCarroll, J.; Saluja, A.K. The role of NFκB activation in the pathogenesis of acute pancreatitis. Gut, 2008, 57, 259-67.
159. Laukkarinen, J.M.; Weiss, E.R.; van Acker, G.J.; Steer, M.L.; Perides, G. Protease-activated receptor-2 exerts contrasting model-specific effects on acute experimental pancreatitis. J. Biol. Chem., 2008, 283(30), 20703-12.
160. Binker, M.G.; Binker-Cosen, A.A.; Gaisano, H.Y.; Cosen-Binker, L.I. Inhibition of Rac1 decreases the severity of pancreatitis and pancreatitis-associated lung injury in mice. Exp. Physiol., 2008, 93(10), 1091-103.
161. Samuel, I.; Yorek, M.A.; Zaheer, A.; Fisher, R.A. Bile-pancreatic juice exclusion promotes Akt/NF-kappaB activation and chemokine production in ligation-induced acute pancreatitis. J. Gastrointest. Surg., 2006, 10(7), 950-9
162. Cosen-Binker, L.I.; Binker, M.G.; Wang, C.C.; Hong, W.; Gaisano, H.Y. VAMP8 is the v-SNARE that mediates basolateral exocytosis in a mouse model of alcoholic pancreatitis. J. Clin. Invest., 2008, 118(7), 2535-51.
163. Nakamura, H.; Tashiro, M.; Asaumi, H.; Nomiyama, Y.; Kaku, M.; Watanabe, S.; Miyamoto, T.; Otsuki, M. Increased expression of Smad6 deteriorates murine acute experimental pancreatitis in two models. Gut, 2008, 57(6), 788-98.
164. Fischer, L.; Gukovskaya, A.S.; Penninger, J.; Mareninova, O.A.; Friess, H.; Gukovsky, I.; Pandol, S.J. Phosphatidylinositol 3-kinase facilitates bile acid-induced Ca2+ responses in pancreatic acinar cells. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 292, G875-86.
165. Barrow, S.L.; Voronina, S.G.; da Silva Xavier, G.; Chvanov, M.A.; Longbottom, R.E.; Gerasimenko, O.V.; Petersen, O.H.; Rutter, G.A.; Tepikin, A.V. ATP depletion inhibits Ca2+ release, influx and extrusion in pancreatic acinar cells but not pathological Ca2+ responses induce by bile. Pflugers Arch., 2008, 455, 1025-39.
166. González, A.; Pariente, J.A., Salido, G.M. Ethanol impairs calcium homeostasis following CCK-8 stimulation in mouse pancreatic acinar cells. Alcohol, 2008, 42(7), 565-73.
167. Gutierrez, P.T.; Folch-Puy, E.; Bulbena, O.; Closa, D. O. Oxidised lipids present in ascitic fluid interfere with the regulation of the macrophages during acute pancreatitis, promoting an exacerbation of the inflammatory response. Gut, 2008, 57(5), 642-8.
168. Husain, S.Z.; Grant, W.M.; Gorelick, F.S.; Nathanson, M.H.; Shah, A.U. Caerulein-induced intracellular pancreatic zymogen activation is dependent on calcineurin. Am. J. Physiol. - Gastrointest. Liver Physiol., 2007, 292(6), G1594-9.
169. Ramnath, R.D.; Sun, J.; Adhikari, S.; Zhi, L.; Bhatia, M. Role of PKC-δ on substance P-induced chemokine synthesis in pancreatic acinar cells. Am. J. Physiol. - Cell Physiol., 2008, 294(3), C683-92.
170. Ramnath, R.D.; Sun, J.; Bhatia, M. Role of calcium in substance P-induced chemokine synthesis in mouse pancreatic acinar cells. Br. J. Pharmacol., 2008, 154(6), 1339-48.
171. Bhagat, L.; Singh, V.P.; Dawra, R.K.; Saluja, A.K. Sodium arsenite induces heat shock protein 70 expression and protects against secretagogue-induced trypsinogen and NF-κB activation. J. Cell. Physiol., 2008, 215(1), 37-46.
172. Yuan, J.; Lugea, A.; Zheng, L.; Gukovsky, I.; Edderkaoui, M.; Rozengurt, E.; Pandol, S.J. Protien kinase D1 mediates NF-κB activation induced by cholecystokinin and cholinergic signaling in pancreatic acinar cells. Am. J. Physiol. Gastrointest. Liver Physiol., 2008, 295(6), G1190-201.
173. Singh, V.P.; Saluja, A.K.; Bhagat, L.; Van Acker, G.J.D.; Song, A.M.; Soltoff, S.P.; Cantley, L.C.; Steer, M.L. Phosphatidylinositol 3-kinase-dependent activation of trypsinogen modulates the severity of acute pancreatitis. J. Clin. Invest., 2001, 108(9), 1387-94.
174. Mackay, C.R. Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat Immunol. 2008, 9(9), 988-98.
175. Griesbacher, T.; Rainer, I.; Tiran, B.; Peskar, B.A. Kallikrein inhibitors limit kinin B(2) antagonist-induced progression of oedematous to haemorrhagic pancreatitis in rats. Br. J. Pharmacol., 2008, 155(6), 865-74.